These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3675609)

  • 41. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiosensitization by hypoxic pretreatment with misonidazole: an interaction of damage at the DNA level.
    Taylor YC; Evans JW; Brown JM
    Radiat Res; 1987 Mar; 109(3):364-73. PubMed ID: 3550868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3H-misonidazole labeling and viability of hypoxic cells in the sandwich system, an in vitro tumor analogue.
    Hlatky L; Ring CS; Sachs RK
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):143-53. PubMed ID: 2912936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
    Stewart FA; Denekamp J; Randhawa VS
    Br J Cancer; 1982 Jun; 45(6):869-77. PubMed ID: 7093121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.
    Urtasun RC; Chapman JD; Raleigh JA; Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1263-7. PubMed ID: 3017905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic binding of misonidazole to mouse tissues. Comparison between labels on the ring and side chain, and the production of tritiated water.
    Franko AJ; Raleigh JA; Sutherland RG; Soderlind KJ
    Biochem Pharmacol; 1989 Feb; 38(4):665-70. PubMed ID: 2917021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductase.
    McManus ME; Lang MA; Stuart K; Strong J
    Biochem Pharmacol; 1982 Feb; 31(4):547-52. PubMed ID: 6802140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
    Workman P; Donaldson J; Smith NC
    Cancer Treat Rep; 1983; 67(7-8):723-5. PubMed ID: 6871889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reductive metabolism and DNA binding of misonidazole.
    Djuric Z
    Toxicol Appl Pharmacol; 1989 Oct; 101(1):47-54. PubMed ID: 2799816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retention of misonidazole in normal and malignant tissues: interplay of hypoxia and reductases.
    Cobb LM; Nolan J; Hacker T
    Int J Radiat Oncol Biol Phys; 1992; 22(4):655-9. PubMed ID: 1544833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA; Workman P
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.
    Parliament MB; Wiebe LI; Franko AJ
    Br J Cancer; 1992 Dec; 66(6):1103-8. PubMed ID: 1280990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
    Born JL; Smith BR; Harper N; Koch CJ
    Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.
    Parliament MB; Franko AJ; Allalunis-Turner MJ; Mielke BW; Santos CL; Wolokoff BG; Mercer JR
    Br J Cancer; 1997; 75(3):311-8. PubMed ID: 9020473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Recent advances in hypoxic cell radiosensitizer].
    Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
    Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.